Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

CJ Tyrrell; P Iversen; T Tammela; J Anderson; T Björk; A Kaisarys; T. Morris

doi:10.1111/j.1464-410x.2006.06275.x

Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

CJ Tyrrell
, P Iversen
, T Tammela
, J Anderson
, T Björk
, A Kaisarys
, T. Morris

Research output: Contribution to journal › Article › Scientific › peer-review

29 Citations (Scopus)

Original language	English
Pages (from-to)	563-572
Journal	BJU International
Volume	98
Issue number	3
DOIs	https://doi.org/10.1111/j.1464-410x.2006.06275.x
Publication status	Published - 2006
Publication type	A1 Journal article-refereed

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

bicalutamide
monotherapy
prostate cancer
survival
tolerability

Access to Document

10.1111/j.1464-410x.2006.06275.x

Cite this

Tyrrell, CJ., Iversen, P., Tammela, T., Anderson, J., Björk, T., Kaisarys, A., & Morris, T. (2006). Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration. BJU International, 98(3), 563-572. https://doi.org/10.1111/j.1464-410x.2006.06275.x

@article{a18695ce71c647cf84b9a00a456190c0,

title = "Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration",

keywords = "bicalutamide, monotherapy, prostate cancer, survival, tolerability, bicalutamide, monotherapy, prostate cancer, survival, tolerability",

author = "CJ Tyrrell and P Iversen and T Tammela and J Anderson and T Bj{\"o}rk and A Kaisarys and T. Morris",

year = "2006",

doi = "10.1111/j.1464-410x.2006.06275.x",

language = "English",

volume = "98",

pages = "563--572",

journal = "BJU International",

issn = "1464-4096",

publisher = "John Wiley and Sons Inc",

number = "3",

}

Tyrrell, CJ, Iversen, P, Tammela, T, Anderson, J, Björk, T, Kaisarys, A & Morris, T 2006, 'Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration', BJU International, vol. 98, no. 3, pp. 563-572. https://doi.org/10.1111/j.1464-410x.2006.06275.x

Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration. / Tyrrell, CJ; Iversen, P; Tammela, T et al.
In: BJU International, Vol. 98, No. 3, 2006, p. 563-572.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Tolerability, efficacy and pharmacokinetics of bicalutamide 300 mg, 450 mg or 600 mg as monotherapy for patients with locally advanced or metastatic prostate cancer, compared with castration

AU - Tyrrell, CJ

AU - Iversen, P

AU - Tammela, T

AU - Anderson, J

AU - Björk, T

AU - Kaisarys, A

AU - Morris, T.

PY - 2006

Y1 - 2006

KW - bicalutamide

KW - monotherapy

KW - prostate cancer

KW - survival

KW - tolerability

KW - bicalutamide

KW - monotherapy

KW - prostate cancer

KW - survival

KW - tolerability

U2 - 10.1111/j.1464-410x.2006.06275.x

DO - 10.1111/j.1464-410x.2006.06275.x

M3 - Article

SN - 1464-4096

VL - 98

SP - 563

EP - 572

JO - BJU International

JF - BJU International

IS - 3

ER -